These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18422756)

  • 1. Coordinate suppression of Sdpr and Fhl1 expression in tumors of the breast, kidney, and prostate.
    Li X; Jia Z; Shen Y; Ichikawa H; Jarvik J; Nagele RG; Goldberg GS
    Cancer Sci; 2008 Jul; 99(7):1326-33. PubMed ID: 18422756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SRC uses Cas to suppress Fhl1 in order to promote nonanchored growth and migration of tumor cells.
    Shen Y; Jia Z; Nagele RG; Ichikawa H; Goldberg GS
    Cancer Res; 2006 Feb; 66(3):1543-52. PubMed ID: 16452211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Src-mediated phosphorylation converts FHL1 from tumor suppressor to tumor promoter.
    Wang X; Wei X; Yuan Y; Sun Q; Zhan J; Zhang J; Tang Y; Li F; Ding L; Ye Q; Zhang H
    J Cell Biol; 2018 Apr; 217(4):1335-1351. PubMed ID: 29434030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-linked FHL1 as a novel therapeutic target for head and neck squamous cell carcinoma.
    Cao W; Liu J; Xia R; Lin L; Wang X; Xiao M; Zhang C; Li J; Ji T; Chen W
    Oncotarget; 2016 Mar; 7(12):14537-50. PubMed ID: 26908444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG hypermethylation of human four-and-a-half LIM domains 1 contributes to migration and invasion activity of human bladder cancer.
    Matsumoto M; Kawakami K; Enokida H; Toki K; Matsuda R; Chiyomaru T; Nishiyama K; Kawahara K; Seki N; Nakagawa M
    Int J Mol Med; 2010 Aug; 26(2):241-7. PubMed ID: 20596604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of epigenetic inactivation of the human four and a half LIM domains 1 gene in human oral cancer.
    Koike K; Kasamatsu A; Iyoda M; Saito Y; Kouzu Y; Koike H; Sakamoto Y; Ogawara K; Tanzawa H; Uzawa K
    Int J Oncol; 2013 Jan; 42(1):141-50. PubMed ID: 23123766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FHL1 on chromosome X is a single-hit gastrointestinal tumor-suppressor gene and contributes to the formation of an epigenetic field defect.
    Asada K; Ando T; Niwa T; Nanjo S; Watanabe N; Okochi-Takada E; Yoshida T; Miyamoto K; Enomoto S; Ichinose M; Tsukamoto T; Ito S; Tatematsu M; Sugiyama T; Ushijima T
    Oncogene; 2013 Apr; 32(17):2140-9. PubMed ID: 22689052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four and a half LIM domains protein 1 can be as a double-edged sword in cancer progression.
    Wei X; Zhang H
    Cancer Biol Med; 2020 May; 17(2):270-281. PubMed ID: 32587768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FHL1 interacts with oestrogen receptors and regulates breast cancer cell growth.
    Ding L; Niu C; Zheng Y; Xiong Z; Liu Y; Lin J; Sun H; Huang K; Yang W; Li X; Ye Q
    J Cell Mol Med; 2011 Jan; 15(1):72-85. PubMed ID: 19840196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FHL1 inhibits the growth of tongue squamous cell carcinoma cells via G1/S cell cycle arrest.
    Ren W; Lian P; Cheng L; Du P; Guan X; Wang H; Ding L; Gao Z; Huang X; Xiao F; Wang L; Bi X; Ye Q; Wang E
    Mol Med Rep; 2015 Sep; 12(3):3958-3964. PubMed ID: 26017856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer.
    Pereira CM; de Carvalho AC; da Silva FR; Melendez ME; Lessa RC; Andrade VCC; Kowalski LP; Vettore AL; Carvalho AL
    BMC Cancer; 2018 Feb; 18(1):193. PubMed ID: 29454310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation and growth inhibitory role of FHL1 in lung cancer.
    Niu C; Liang C; Guo J; Cheng L; Zhang H; Qin X; Zhang Q; Ding L; Yuan B; Xu X; Li J; Lin J; Ye Q
    Int J Cancer; 2012 Jun; 130(11):2549-56. PubMed ID: 21702045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FHL1 and Smad4 synergistically inhibit vascular endothelial growth factor expression.
    Zhou Z; Lu J; Dou J; Lv Z; Qin X; Lin J
    Mol Med Rep; 2013 Feb; 7(2):649-53. PubMed ID: 23184087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FHL1 promotes glioblastoma aggressiveness through regulating EGFR expression.
    Sun L; Chen L; Zhu H; Li Y; Chen CC; Li M
    FEBS Lett; 2021 Jan; 595(1):85-98. PubMed ID: 33053208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SDPR functions as a metastasis suppressor in breast cancer by promoting apoptosis.
    Ozturk S; Papageorgis P; Wong CK; Lambert AW; Abdolmaleky HM; Thiagalingam A; Cohen HT; Thiagalingam S
    Proc Natl Acad Sci U S A; 2016 Jan; 113(3):638-43. PubMed ID: 26739564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FHL family members suppress vascular endothelial growth factor expression through blockade of dimerization of HIF1α and HIF1β.
    Lin J; Qin X; Zhu Z; Mu J; Zhu L; Wu K; Jiao H; Xu X; Ye Q
    IUBMB Life; 2012 Nov; 64(11):921-30. PubMed ID: 23086815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-410 is overexpressed in liver and colorectal tumors and enhances tumor cell growth by silencing FHL1 via a direct/indirect mechanism.
    Wang Y; Fu J; Jiang M; Zhang X; Cheng L; Xu X; Fan Z; Zhang J; Ye Q; Song H
    PLoS One; 2014; 9(10):e108708. PubMed ID: 25272045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four-and-a-half LIM protein 1 promotes paclitaxel resistance in hepatic carcinoma cells through the regulation of caspase-3 activation.
    Zhou L; Ding L; Liu J; Zhang Y; Luo X; Zhao L; Ren J
    J Cancer Res Ther; 2018 Sep; 14(Supplement):S767-S773. PubMed ID: 30249901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-3682-3p promotes esophageal cancer progression by targeting FHL1 and activating the Wnt/β-catenin signaling pathway.
    Cai Y; Xia L; Zhu H; Cheng H; Tian Y; Sun L; Wang J; Lu N; Wang J; Chen Y
    Cell Signal; 2024 Jul; 119():111155. PubMed ID: 38565413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine phosphorylation within the SH3 domain regulates CAS subcellular localization, cell migration, and invasiveness.
    Janoštiak R; Tolde O; Brůhová Z; Novotný M; Hanks SK; Rösel D; Brábek J
    Mol Biol Cell; 2011 Nov; 22(22):4256-67. PubMed ID: 21937722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.